nifedipine 30 mg

INDICATION AND USAGE Nifedipine extended-release tablets are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Aurobindo Pharma Limited

FDA Reported Adverse Reactions
`[1] fatigue` `[2] dyspnoea` `[3] drug ineffective` `[4] diarrhoea` `[5] nausea` `[6] off label use` `[7] dizziness` `[8] headache` `[9] asthenia` `[10] pain`

12 months ago

ROUND ORANGE NF 30

12 months ago

NF 30 ROUND ORANGE

HOW SUPPLIED

NIFEDIPINE Extended-Release Tablets USP, 30 mg are orange, round, biconvexed, film-coated tablets debossed with “NF” on one side and “30” on other side. They are supplied as follows: Bottles of 100 NDC 59651-295-01

NIFEDIPINE Extended-Release Tablets USP, 60 mg are yellow, round, biconvexed, film-coated tablets debossed with “NF” on one side and “60” on other side. They are supplied as follows: Bottles of 100 NDC 59651-296-01

NIFEDIPINE Extended-Release Tablets USP, 90 mg are pink, round, biconvexed, film-coated tablets debossed with “NF” on one side and “90” on other side. They are supplied as follows: Bottles of 100 NDC 59651-297-01 The tablets should be protected from light and moisture and store at 20° to 25°C (68° to 77°F); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant containers. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: June 2021

More pills like ROUND NF 30

Related Pills

nifedipine 90 mg

aurobindo pharma limited

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site